UNKNOWN SOLITAIRE
Report
- Report Number
- 2029214-2021-01324
- Event Type
- Injury
- Date Received
- October 22, 2021
- Date of Event
- March 8, 2019
- Report Date
- October 22, 2021
- Manufacturer
- MICRO THERAPEUTICS, INC. DBA EV3
- Product Code
- NRY
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- KS
- Reporter Occupation
- PHYSICIAN
Narratives
SEE MANUFACTURER REPORT # 2029214-2021-01323 FOR ANOTHER REPORT FROM THIS LITERATURE ARTICLE. KIM B, KIM BM, BANG OY, ET AL. CAROTID ARTERY STENTING AND INTRACRANIAL THROMBECTOMY FOR TANDEM CERVICAL AND INTRACRANIAL ARTERY OCCLUSIONS. NEUROSURGERY. 2020;86(2):213-220. DOI:10.1093/NEUROS/NYZ026. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.
KIM B, KIM BM, BANG OY, ET AL. CAROTID ARTERY STENTING AND INTRACRANIAL THROMBECTOMY FOR TANDEM CERVICAL AND INTRACRANIAL ARTERY OCCLUSIONS. NEUROSURGERY. 2020;86(2):213-220. DOI:10.1093/NEUROS/NYZ026 MEDTRONIC LITERATURE REVIEW FOUND A REPORT OF PATIENT COMPLICATIONS IN ASSOCIATION WITH A SOLITAIRE DEVICE. THE ARTICLE DOES NOT STATE ANY TECHNICAL ISSUES DURING USE OF THE SOLITAIRE. THE PURPOSE OF THIS ARTICLE WAS TO INVESTIGATE THE EFFICACY AND SAFETY OF CAROTID ARTERY STENTING (CAS) IN COMBINATION WITH ENDOVASCULAR THROMBECTOMY (CAS-EVT) IN CERVICAL INTERNAL CAROTID ARTERY OCCLUSION (CICAO) - LARGE VESSEL OCCLUSION (LVO) PATIENTS AND TO COMPARE ITS OUTCOMES WITH THOSE OF EVT WITHOUT CAS (EVT-ALONE). OF THE 955 PATIENTS WHO UNDERWENT EVT, 75 PATIENTS (7.9%) HAD CICAO-LVO. FIFTY-SIX PATIENTS UNDERWENT CAS-EVT (74.6%), AND THE REMAINING 19 PATIENTS UNDERWENT EVT-ALONE (25.4%). THE FOLLOWING INTRA- OR POST-PROCEDURAL OUTCOMES WERE NOTED: -THERE WERE 70 INSTANCES OF SYMPTOMATIC INTRACRANIAL HEMORRHAGE (52 LVO ALONE, 9 TANDEM CICAO-LVO), 3 EVT ALONE, 6 CAS-EVT). -THERE WERE 8 INSTANCES OF RE-OCCLUSION OCCURRED DURING THE PROCEDURE (3 EVT ALONE, 5 CAS-EVT). HIGH RATES OF RE-OCCLUSION (66%) AND RESIDUAL STENOSIS OF THE CICA HAVE BEEN OBSERVED IN PATIENTS WHO UNDERWENT ANGIOPLASTY WITH DEFENSIVE STENT PLACEMENT FOR ACUTE TANDEM OCCLUSIONS. -THERE WERE 10 CASES (17.8%) OF IN-STENT THROMBOSIS REQUIRING GLYCOPROTEIN IIB/IIIA INHIBITOR INFUSION.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1583132 | UNKNOWN SOLITAIRE | CATHETER, THROMBUS RETRIEVER | NRY | MICRO THERAPEUTICS, INC. DBA EV3 | UNK-NV-SOLITAIRE | UNKNOWN |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 68 YR | Required Intervention |